We continue to observe significant advances in HIV antiretroviral therapy, with HIV positive patients living as long as patients without HIV. This presentation will discuss the available treatment options for HIV therapy, including the current recommended therapies for treatment naïve and treatment experienced patients. There are several medications in the pipeline, including long-acting antiretrovirals, which will allow for once-a-month IM injections. HIV prophylaxis is available as PrEP and PEP to decrease the incidence of HIV infection in patients with high-risk behaviors or those with an exposure to an HIV-positive individual. Government programs are also in place, which when combined with the previously mentioned strategies, will be crucial in decreasing the incidence of new HIV infections, with the hope of eliminating HIV altogether.
Objectives:- Discuss available antiretroviral agents and recommended therapy.
- Determine indications and appropriate treatment for occupational post-exposure prophylaxis.
